Latest filing published 04 Mar 2026 for Ventyx Biosciences, Inc.. Read the official filing
Roy Gonzales discloses dealings in Ventyx Biosciences, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 15 May 2025 to 4 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 4 March 2026, reports a transaction in Ventyx Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations